darifenacin hydrobromide and its Impurities
Darifenacin Hydrobromide blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. It is a medication used to treat urinary incontinence.. Reference standards of Darifenacin Hydrobromide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
 
	
			                                   
																				N-(((S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)pyrrolidin-1-yl)methyl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
N-(((S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)pyrrolidin-1-yl)methyl)-2-((S)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
- Catalogue No.:PA 04 87080 
- CAS : - NA
- Molecular Formula : C47H50N4O3 
- Molecular Weight : 718.94 

 
																				 
																				![(3S)-1-[2-(3-Ethenyl-4-hydroxyphenyl)ethyl]-α,α- PA 04 87520](https://www.pharmaffiliates.com/pimages/PA0487520.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![(S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrr PA 04 87620](https://www.pharmaffiliates.com/pimages/PA0487620.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diph PA 04 0871012](https://www.pharmaffiliates.com/pimages/PA040871012.jpg) 
																				 
																				 
																				 
																				 
 
 
 
